GoHealth (GOCOQ) Research & Development (2019 - 2026)

GoHealth (GOCOQ) has 8 years of Research & Development data on file, last reported at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 86.82% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $35.9 million (down 56.29% YoY), and the FY2025 full-year result was $106.0 million, up 158.36% from the prior year.
• Research & Development slipped to $6.8 million in Q1 2026, from $10.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $75.2 million in Q4 2023 to a low of -$150.1 million in Q4 2022.
• A 5-year average of $14.3 million and a median of $10.9 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development sank 87.25% in 2022 and jumped 390.03% in 2025, its largest moves.
• Tracing GOCOQ's Research & Development over 5 years: stood at -$150.1 million in 2022, then soared by 150.11% to $75.2 million in 2023, then slumped by 83.88% to $12.1 million in 2024, then dropped by 9.89% to $10.9 million in 2025, then tumbled by 37.63% to $6.8 million in 2026.
• Business Quant data shows GOCOQ's Research & Development at $6.8 million in Q1 2026, $10.9 million in Q4 2025, and $10.0 million in Q3 2025.